Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;66(12):2117-2142.
doi: 10.1007/s00234-024-03493-x. Epub 2024 Oct 24.

Response assessment in pediatric neurooncology (RAPNO) criteria revisited: a practical navigation guide for neuroradiologists

Affiliations
Review

Response assessment in pediatric neurooncology (RAPNO) criteria revisited: a practical navigation guide for neuroradiologists

Ana Filipa Geraldo et al. Neuroradiology. 2024 Dec.

Abstract

The Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group is an international, collaborative network of experts dedicated to pediatric central nervous system (CNS) tumors that was created in 2011. Since then, six RAPNO articles with imaging guidelines for response assessment in diverse pediatric tumor subgroups have been published, namely: 1) medulloblastomas and leptomeningeal seeding tumors (2018), 2) pediatric high-grade gliomas (2020), 3) pediatric low-grade gliomas (2020), 4) diffuse intrinsic pontine gliomas (2020), 5) pediatric intracranial ependymomas (2022) and 6) pediatric craniopharyngiomas (2023). The purpose of this article is to review all current available RAPNO criteria using a systematized and comparative approach centered on the role of neuroradiologists and supported by neuroimaging examples. Special emphasis will be placed on clarification of core concepts as well as practical adoption aspects of the RAPNO guidelines, namely how and when to image the brain and/or the spine; how to interpret the imaging findings; which other clinical, therapeutic and laboratory variables to consider; and finally how to apply the information to attribute the final appropriate response assessment classification.

Keywords: Brain tumor; Central Nervous System Neoplasms; Neuroimaging; Pediatrics; Spinal cord tumor.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval: All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent: For this type of study formal consent is not required. Conflict of interest: The authors declare that they have no conflict of interest.

References

    1. Warren KE, Poussaint TY, Vezina G et al (2013) Challenges with defining response to antitumor agents in pediatric neuro-oncology: A report from the response assessment in pediatric neuro-oncology. Pediatr Blood Cancer 60:1397–1401. https://doi.org/10.1002/pbc.24562 - DOI - PubMed - PMC
    1. Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972. https://doi.org/10.1200/JCO.2009.26.3541 - DOI - PubMed
    1. Ostrom QT, Price M, Neff C et al (2022) CBTRUS Statistical report: primary brain and other central nervous system tumors diagnosed in the united states in 2015–2019. Neuro Oncol 24:V1–V95. https://doi.org/10.1093/neuonc/noac202 - DOI - PubMed - PMC
    1. Warren KE, Vezina G, Poussaint TY et al (2018) Response assessment in medulloblastoma and leptomeningeal seeding tumors: Recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Neuro Oncol 20:13–23. https://doi.org/10.1093/neuonc/nox087 - DOI - PubMed
    1. Fangusaro J, Witt O, Hernáiz Driever P et al (2020) Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 21:e305–e316. https://doi.org/10.1016/S1470-2045(20)30064-4 - DOI - PubMed

MeSH terms

LinkOut - more resources